Clinical trial
Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave…
NCT00409227 · Assaf-Harofeh Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00409227 |
|---|---|
| Title | Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy |
| Official title | Prospective Randomized Placebo Controlled Blinded Study to Evaluate the Efficacy of Alfuzosin (Alpha Blocker) on the Success Rates Following SWL. |
| Lead sponsor | Assaf-Harofeh Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urolithiasis, Nephrolithiasis, Ureterolithiasis |
| Intervention type | Drug |
| Interventions | Alpha blocker-alfuzosin, placebo |
| Enrollment | 150 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2009 |
| First posted | Dec 8, 2006 |
| Last update posted | Jun 18, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: